Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03606668 · ClinicalTrials.gov registry record · NA
Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03606668 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT03606668, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.
Interventions
- DEVICE HTC Vive Virtual Reality (VR) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03606668
The ClinicalTrials.gov registry entry for NCT03606668 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HTC Vive Virtual Reality (VR) system is the first listed.
NCT03606668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03606668 about?
NCT03606668 is a clinical study titled "Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders". Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and redu...
What is the current status of trial NCT03606668?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-06-20. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT03606668?
The interventions under investigation include: HTC Vive Virtual Reality (VR) system (DEVICE).
Who is sponsoring clinical trial NCT03606668?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.